Surgenex

Scottsdale, United States Founded: 2015 • Age: 11 yrs
Processes and provides allograft tissues and orthobiologic products for healthcare providers.

About Surgenex

Surgenex is a company based in Scottsdale (United States) founded in 2015 by Abel Bullock. It operates as a B2B. The company has 140 employees as of December 31, 2023. Surgenex offers products and services including SurGraft®, SurSight®, ArdeoGraft®, and PelloGraft®. Surgenex operates in a competitive market with competitors including MaxCyte, SQZBiotech, Berkeley Lights, Gemini Bio and Fluxion Biosciences, among others.

  • Headquarter Scottsdale, United States
  • Employees 140 as on 31 Dec, 2023
  • Founders Abel Bullock
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Surgenex Llc
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    140

    as on Dec 31, 2023

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Surgenex

Surgenex offers a comprehensive portfolio of products and services, including SurGraft®, SurSight®, ArdeoGraft®, and PelloGraft®. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Amniotic membrane product for protective therapeutic applications.

Ophthalmic product using amniotic membrane for eye treatments.

Allograft for surgical applications in tissue repair.

Bone matrix implant for promoting new bone formation.

People of Surgenex
Headcount 10-50
Employee Profiles 17
Employee Profiles
People
Abel Bullock
President & CEO
People
Dan Robinson
CFO
People
Brian Stoor
President Of Operations
People
Pamela McKeown
Vice President, Government Affairs And Health Policy

Unlock access to complete

Funding Insights of Surgenex

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by Surgenex

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Surgenex

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Surgenex Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Surgenex

Surgenex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MaxCyte, SQZBiotech, Berkeley Lights, Gemini Bio and Fluxion Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Instrument systems for cell processing and modification are provided.
domain founded_year HQ Location
Cell therapies are developed using proprietary Cell Squeeze technology.
domain founded_year HQ Location
Microfluidics-based systems for single-cell isolation and analysis are developed.
domain founded_year HQ Location
Supplement reagents for cell and gene therapy are manufactured.
domain founded_year HQ Location
Microfluidics-based tools for cellular analysis are provided.
domain founded_year HQ Location
Developer of automated cell culture instruments
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Surgenex

Frequently Asked Questions about Surgenex

When was Surgenex founded?

Surgenex was founded in 2015.

Where is Surgenex located?

Surgenex is headquartered in Scottsdale, United States. It is registered at Scottsdale, Arizona, United States.

Who is the current CEO of Surgenex?

Abel Bullock is the current CEO of Surgenex. They have also founded this company.

How many employees does Surgenex have?

As of Dec 31, 2023, the latest employee count at Surgenex is 140.

What does Surgenex do?

Surgenex focuses on processing and distributing high-quality allograft tissues through patented methods like Excellion, ensuring safety and efficacy. The company operates from Scottsdale, Arizona, serving hospitals, private offices, and ambulatory surgical centers via partnerships and contract manufacturing. It emphasizes regulatory compliance and therapeutic benefits in areas like bone and soft tissue repair.

Who are the top competitors of Surgenex?

Surgenex's top competitors include MaxCyte, SQZBiotech and Mytos.

What products or services does Surgenex offer?

Surgenex offers SurGraft®, SurSight®, ArdeoGraft®, and PelloGraft®.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available